APLS Apellis Pharmaceuticals

Watchlist

Close Apr 26 16:00 ET

Post 16:01 ET

6.05BMarket Cap-11204P/E (TTM)

Apellis Pharmaceuticals Stock Analyst Ratings & Price Target

Updated: Apr 18, 2024

Based on 13 analysts giving stock ratings to Apellis Pharmaceuticals in the past 3 months

Strong Buy

Updated: Apr 18, 2024

The average Apellis Pharmaceuticals stock price target is 83.23 with a max estimate of 110.00 and a min estimate of 60.00

Review Apellis Pharmaceuticals earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 18, 2024

Strong Buy

Updated: Apr 18, 2024

Overall